US FDA selects 13 drug makers for supply chain pilot
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration on 18 February revealed the first 13 companies that have prequalified to take part in a pilot program aimed at assisting the agency in its efforts to prevent the importation of adulterated, misbranded or unapproved drugs1.